Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Early contraceptive failure of Implanon in an HIV-seropositive patient on triple antiretroviral therapy with zidovudine, lamivudine and efavirenz.

× No keyword cloud information.

16 in total

1. Efavirenz decreases etonogestrel exposure: a pharmacokinetic evaluation of implantable contraception with antiretroviral therapy.

Authors: Catherine A Chappell; Mohammed Lamorde; Shadia Nakalema; Beatrice A Chen; Hope Mackline; Sharon A Riddler; Susan E Cohn; Kristin M Darin; Sharon L Achilles; Kimberly K Scarsi
Journal: AIDS Date: 2017-09-10 Impact factor: 4.177

2. Interactions between etonogestrel-releasing contraceptive implant and 3 antiretroviral regimens.

Authors: Regis Kreitchmann; Alice Stek; Brookie M Best; Edmund Capparelli; JiaJia Wang; David Shapiro; Nahida Chakhtoura; Mark Mirochnick; Ahizechukwu C Eke
Journal: Contraception Date: 2021-08-15 Impact factor: 3.375

Review 3. Effects of hormonal contraception on antiretroviral drug metabolism, pharmacokinetics and pharmacodynamics.

Authors: Andrea R Thurman; Sharon Anderson; Gustavo F Doncel
Journal: Am J Reprod Immunol Date: 2014-02-13 Impact factor: 3.886

4. Effectiveness of hormonal contraception in HIV-infected women using antiretroviral therapy.

Authors: Maria Pyra; Renee Heffron; Nelly R Mugo; Kavita Nanda; Katherine K Thomas; Connie Celum; Athena P Kourtis; Edwin Were; Helen Rees; Elizabeth Bukusi; Jared M Baeten
Journal: AIDS Date: 2015-11 Impact factor: 4.177

5. Pharmacokinetic interactions between the hormonal emergency contraception, levonorgestrel (Plan B), and Efavirenz.

Authors: Monica L Carten; Jennifer J Kiser; Awewura Kwara; Samantha Mawhinney; Susan Cu-Uvin
Journal: Infect Dis Obstet Gynecol Date: 2012-02-28

6. Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study.

Authors: Mariia Patyka; Daniel Malamud; Drew Weissman; William R Abrams; Zoya Kurago
Journal: PLoS One Date: 2015-07-14 Impact factor: 3.240

7. Contraceptive use among HIV-infected women and men receiving antiretroviral therapy in Lusaka, Zambia: a cross-sectional survey.

Authors: Nancy L Hancock; Carla J Chibwesha; Samuel Bosomprah; Jonathan Newman; Mwangelwa Mubiana-Mbewe; Elizabeth Siyama Sitali; Carolyn Bolton-Moore; Clara Mbwili-Muleya; Benjamin H Chi
Journal: BMC Public Health Date: 2016-05-12 Impact factor: 3.295

Review 8. Contraception for the HIV-positive woman: a review of interactions between hormonal contraception and antiretroviral therapy.

Authors: Jennifer A Robinson; Roxanne Jamshidi; Anne E Burke
Journal: Infect Dis Obstet Gynecol Date: 2012-08-14

Review 9. Pregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort study.

Authors: Rena C Patel; Maricianah Onono; Monica Gandhi; Cinthia Blat; Jill Hagey; Starley B Shade; Eric Vittinghoff; Elizabeth A Bukusi; Sara J Newmann; Craig R Cohen
Journal: Lancet HIV Date: 2015-10-22 Impact factor: 12.767

10. Unintended Pregnancies Observed With Combined Use of the Levonorgestrel Contraceptive Implant and Efavirenz-based Antiretroviral Therapy: A Three-Arm Pharmacokinetic Evaluation Over 48 Weeks.

Authors: Kimberly K Scarsi; Kristin M Darin; Shadia Nakalema; David J Back; Pauline Byakika-Kibwika; Laura J Else; Sujan Dilly Penchala; Allan Buzibye; Susan E Cohn; Concepta Merry; Mohammed Lamorde
Journal: Clin Infect Dis Date: 2015-12-08 Impact factor: 9.079